|
ACI : Conference-Papers : 2005 : Pharma and Biotech In-licensing, Co-development and co-promotion Agreements
8th Forum onPharma and Biotech In-licensing, Co-development and co-promotion AgreementsNegotiating and Drafting Creative and Flexible Agreements to Maximize Profits in the U.S. and Global Pharmaceutical and Biotech MarketplacesMonday, November 15, 2004
AboutDo you have the information and skills you need to structure, negotiate, and manage complex deals that will expand your company's business, both in the U.S. and internationally?Today, virtually all pharmaceutical companies are seeking product candidates-ranging from late-stage drugs to early discovery-stage contenders-in an effort to fill depleted product pipelines. To accomplish this goal, pharmaceutical and biotech companies are partnering with each other and research institutions through in-licensing (and out-licensing), co-development and co-promotion. The challenge today, however, is this: how do you creatively negotiate and structure these complex, multi-layered collaborations to endure the twists and turns that occur over the long course of product discovery and development in the domestic and international marketplaces? With the high stakes surrounding these collaborations, it is imperative that in-house counsel, senior business executives and attorneys advising the pharmaceutical and biotech industries have an up-to-the-minute and in-depth understanding of the legal and business issues surrounding today's complex in-licensing, co-development and co-promotion transactions. American Conference Institute's 8th Forum on Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements will provide you with the tools you need to create sound and strategically effective agreements. An expert faculty of leading pharmaceutical and biotech in-house counsel and executives, as well as expert attorneys and investment bankers, will provide must-have insights. Contents & ContributorsAboutDo you have the information and skills you need to structure, negotiate, and manage complex deals that will expand your company's business, both in the U.S. and internationally?Today, virtually all pharmaceutical companies are seeking product candidates-ranging from late-stage drugs to early discovery-stage contenders-in an effort to fill depleted product pipelines. To accomplish this goal, pharmaceutical and biotech companies are partnering with each other and research institutions through in-licensing (and out-licensing), co-development and co-promotion. The challenge today, however, is this: how do you creatively negotiate and structure these complex, multi-layered collaborations to endure the twists and turns that occur over the long course of product discovery and development in the domestic and international marketplaces? With the high stakes surrounding these collaborations, it is imperative that in-house counsel, senior business executives and attorneys advising the pharmaceutical and biotech industries have an up-to-the-minute and in-depth understanding of the legal and business issues surrounding today's complex in-licensing, co-development and co-promotion transactions. American Conference Institute's 8th Forum on Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements will provide you with the tools you need to create sound and strategically effective agreements. An expert faculty of leading pharmaceutical and biotech in-house counsel and executives, as well as expert attorneys and investment bankers, will provide must-have insights. Contents & ContributorsHOT BUTTONS IN DUE DILIGENCE AND RISK ASSESSMENTThomas Kowalski, Frommer Lawrence & Haug LICENSE AS PART OF A PATENT SETTLEMENT Karen Bokat, Wiley Rein & Fielding LLP ANTITRUST GUIDELINES FOR THE LICENSING OF INTELLECTUAL PROPERTY Steve Stack, Dechert LLP CONSIDERATIONS WHEN DRAFTING INDUSTRY LICENSING AGREEMENTS Jan Reid, Wyeth Vaccines CONSIDERATIONS WHEN DRAFTING INDUSTRY LICENSING AGREEMENTS Jerry Cohen, Cohen, Tauber, Spievack & Wagner LLP STRUCTURING "WIN-WIN" IN-LICENSING AND CO-DEVELOPMENT COLLABORATIONS WITH UNIVERSITIES Susan Galli, Ropes & Gray Jonathan Lourie, Edwards & Angell, LLP CO-PROMOTION COLLABORATIONS: CONSIDERATIONS AND STRATEGIES FOR A WINNING DEAL Philip Hahn, Pfizer, Inc. CO-PROMOTION COLLABORATIONS: CONSIDERATIONS AND STRATEGIES FOR A WINNING DEAL Barclay Kamb, Cooley Godward LLP HOW TO PLAY THE END GAME: THE ART AND SCIENCE OF TERMINATION Larry Tauber, Cohen, Tauber, Spievack & Wagner LLP TAKING YOUR UNITED STATES AGREEMENT OVERSEAS: INTERNATIONAL CONCERNS IN IN-LICENSING, CO-DEVELOPMENT, AND CO-PROMOTION AGREEMENTS Joel Wolfson, Blank Rome LLP EUROPEAN COLLABORATION AND LICENSE AGREEMENTS David Hull, Covington & Burling Colin Sainsbury, BCM Hanby Wallace Solicitors |
Date: Mon, Nov 15, 2004 Location:
Philadelphia, PA Pricing:
Option 1: Bundle Package
Binder & CD-ROM Save 299 - Best Value! Total: $699 + applicable taxes Option 2: CD-ROM
CD-ROM of program proceedings Total: $499 + applicable taxes Option 3: Binder
Printed copy of program proceedings Total: $499 |
 |
Publication Details |
Copyright 2007 C5 Group Inc. All Rights Reserved. |